Pediatric Skin Research,LLC

Coral Gables, Florida 33146

1 studies enrolling now · 8 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Dominant Dystrophic Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa, Moderate-to-severe Atopic Dermatitis, NonSegmental Vitiligo, Plaque Psoriasis, Recessive Dystrophic Epidermolysis Bullosa

Studies at this site

• Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib — Recruiting now
• A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2) — Running, not enrolling
• A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis — Running, not enrolling
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age — Completed
• Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB — Completed